Bico Group Ab Class B · OMXSTO:BICO

Bico Group Ab Class B — Merger or Acquisition (December 2021)

18 slides from Bico Group Ab Class B's merger presentation, Dec 16, 2021

  1. Slide 1: Acquisition of Biosero

    PRESENTATION Acquisition of Biosero December 16, 2021 | 10am CET/3pm CET

  2. Slide 2: Agenda and speakers

    • Rationale for the acquisition Erik Gatenholm, CEO and Co-founder BICO • The transaction in brief Gusten Danielsson, CFO and Co-founder, BICO and Tom Gilman, CEO and Co-founder, Biosero Agenda and speakers • Synergies Biosero and BICO Dr. Jonas Schöndube, SVP and Business Area Director, Biosciences

  3. Slide 3: Accelerating BICO's Core Capabilities

    Rationale for the acquisition Accelerating BICO’s Core Capabilities – Connecting previously acquired hardware solutions REAGENT & CONSUMABLES SOLUTIONS Data Reproducibility HARDWARE SOLUTIONS BIO CONVERGENCE Data Creation SOLUTIONS SOFTWARE Health Decisions SOLUTIONS Data Capture © BICO 2021, All ri

  4. Slide 4: Delivering on our 2021 strategy, communicated during our CMD in May 2021

    Rationale for the acquisition Delivering on our 2021 strategy, communicated during our CMD in May 2021: Slide from presentation for Business Area, Biosciences from CMD in May 2021 © BICO 2021, All rights reserved.

  5. Slide 5: Transaction in brief

    Transaction in brief Transaction in brief Biosero is a leading software provider for automated Discussions initiated in March 2021. This acquisition is the workflows and laboratory connectivity. main reason for the financing round in October 2021. Enterprise value approximately 165 MUSD (63% in cash

  6. Slide 6: Biosero has shown strong sales and EBITDA

    The transaction in brief Biosero has shown strong sales and EBITDA* MUSD 30 30% 26,00 25 27% 25% 20,30 20 22% 20% 15 15% 11,90 10 10% 7,0 4,4 5 7% 5% 0,8 0 0% 2019A 2020A 2021F Revenue EBITDA EBITDA, % * US GAAP © BICO 2021, All rights reserved.

  7. Slide 7: Biosero in brief

    The transaction in brief Biosero in brief • Founded in 2003 and based in San Diego, US with 75 employees globally • Biosero offers software under the Green Button Go umbrella and services to connect multiple instruments in a lab using robots for lab automation and lab connectivity to allow fully aut

  8. Slide 8: Smart software that integrates instruments to automated workflows

    Synergies Biosero and BICO 1. Smart software that integrates instruments to automated workflows 2. Accelerate BICO’s • The addition of Biosero’s software capabilities brings software capabilities immediate synergies and will allow BICO to offer its customers fully automated and connected workflow so

  9. Slide 9: Biosero software connects BICO instruments to automated workflows

    Synergies Biosero and BICO Biosero software connects BICO instruments to automated workflows Tentative example for potential synergies CYTENA C.WASH DISPENDIX I.DOT QInstruments CELLENION Q1 Bioshaker MatTek CellenONE Omics EpiDerm Sample Prep. CYTENA Liquid UP.SIGHT dispenser Mixing & temperature c

  10. Slide 10: C.STATION and Green Button Go

    Synergies Biosero and BICO EXISTING COLLABORATION: C.STATION and Green Button Go © BICO 2021, All rights reserved.

  11. Slide 11: Global laboratory automation software market

    Synergies Biosero and BICO Global laboratory automation software market Billion USD Fastest growing market: Asia Pacific 1,8 1,6 Largest market: 1,4 North America 1,2 Major players: 1,0 ThermoFisher Scientific, 0,8 1.6 Danaher Corporation, 0,6 1.1 Hudson Robotics, Becton, Dickinson and Company 0,4 (

  12. Slide 12: Focus during the first month as a BICO family member

    Focus and next steps 1. Onboarding and start implementing the 100-day plan, work led by Business Area Focus during the Director and Biosero’s CEO first month as a 2. Focus to deliver on identified synergies BICO family member 3. Alignment to BICO Group functions work streams e.g., financial reportin

  13. Slide 13: BICO's 20 MUSD investment to accelerate Biosero's commercial agenda

    Focus and next steps BICO’s 20 MUSD investment will enable Biosero to further accelerate the commercial agenda and to fully monetize on current order pipeline Global commercial expansion via investments in stronger geographical Accelerate product presence on the US East Coast, development capabiliti

  14. Slide 14: Priorities going forward

    Focus and next steps Priorities going forward Financial targets > 35% organic growth Integration of the Communications and positive EBITDA Group companies to investors © BICO 2021, All rights reserved.

  15. Slide 15: Successful integration of acquisitions

    Focus and next steps Successful integration of acquisitions EV/sales multiples EV/sales multiples EV/sales multiples (in 36 months) (in 26 months) (in 14 months) 15 8 4 6 3 10 ~ 3.7x ~11.0x 4 ~7.0x 2 5 ~2.7x 2 ~3.0- 1 ~1.0x 5.0x 0 0 0 • €5 MM in transaction • ~€30 MM in transaction • ~€80 MM in tran

  16. Slide 16: Q&A

    Q&A © BICO 2021, All rights reserved.

  17. Slide 17: © BICO 2021, All rights reserved.

    © BICO 2021, All rights reserved.

  18. Slide 18: Disclaimer

    Disclaimer You must read the following before continuing. The following applies to this document and the information provided in this presentation by BICO AB (publ) (the “Company”) or any person on behalf of the Company and any other material distributed or statements made in connection with such pr

BICO Group — Merger or Acquisition (December 2021) on 6ix